Neuromuscular Blocker [EPC]

Neuromuscular Blocker [EPC] was reported 99109 times

These side effects are most commonly reported by patients taking drugs of the Neuromuscular Blocker [EPC] class:

# Drug class Count
0 DRUG INEFFECTIVE 33257
1 OFF LABEL USE 18517
2 HEADACHE 6048
3 THERAPEUTIC RESPONSE DECREASED 5305
4 PRODUCT PREPARATION ERROR 4403
5 INJECTION SITE PAIN 4277
6 EYELID PTOSIS 3817
7 MIGRAINE 3563
8 NAUSEA 3398
9 PAIN 3192
10 DIZZINESS 3045
11 FATIGUE 3037
12 MUSCULAR WEAKNESS 2914
13 MULTIPLE USE OF SINGLE-USE PRODUCT 2869
14 DYSPNOEA 2521
15 ASTHENIA 2389
16 DYSPHAGIA 2369
17 HYPOAESTHESIA 2230
18 PRODUCT USE IN UNAPPROVED INDICATION 2014
19 RASH 1984
20 DEATH 1958
21 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1919
22 NECK PAIN 1877
23 PARAESTHESIA 1877
24 VISION BLURRED 1829
25 VOMITING 1775
26 THERAPEUTIC PRODUCT EFFECT DECREASED 1730
27 MALAISE 1653
28 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1642
29 HYPERSENSITIVITY 1638
30 SWELLING FACE 1617
31 INJECTION SITE SWELLING 1591
32 MUSCLE SPASMS 1557
33 URTICARIA 1557
34 SWELLING 1530
35 DRUG INTOLERANCE 1501
36 DIARRHOEA 1481
37 THERAPEUTIC RESPONSE SHORTENED 1466
38 ARTHRALGIA 1457
39 CONDITION AGGRAVATED 1431
40 ANXIETY 1412
41 DEPRESSION 1406
42 DRY MOUTH 1320
43 PRODUCT QUALITY ISSUE 1318
44 PRODUCT STORAGE ERROR 1311
45 ALOPECIA 1289
46 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1253
47 HYPERTENSION 1252
48 INSOMNIA 1249
49 FALL 1204
50 MATERNAL EXPOSURE DURING PREGNANCY 1202
51 INFLUENZA LIKE ILLNESS 1191
52 ABDOMINAL PAIN UPPER 1187
53 PRURITUS 1179
54 PRODUCT PREPARATION ISSUE 1145
55 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1138
56 PNEUMONIA 1136
57 CONFUSIONAL STATE 1131
58 MEMORY IMPAIRMENT 1128
59 MUSCULOSKELETAL STIFFNESS 1122
60 GASTROOESOPHAGEAL REFLUX DISEASE 1121
61 PAIN IN EXTREMITY 1094
62 BLEPHAROSPASM 1051
63 DRUG HYPERSENSITIVITY 1049
64 EPILEPSY 1042
65 FEELING ABNORMAL 1035
66 FACIAL PARESIS 1032
67 OVERDOSE 1023
68 PYREXIA 1008
69 ABDOMINAL DISCOMFORT 996
70 INTENTIONAL PRODUCT USE ISSUE 992
71 NASOPHARYNGITIS 985
72 WEIGHT INCREASED 961
73 INJECTION SITE ERYTHEMA 956
74 GENERAL PHYSICAL HEALTH DETERIORATION 930
75 RHEUMATOID ARTHRITIS 924
76 INFLAMMATION 920
77 SYSTEMIC LUPUS ERYTHEMATOSUS 919
78 ERYTHEMA 903
79 PERIPHERAL SWELLING 903
80 HYPERHIDROSIS 898
81 PSORIATIC ARTHROPATHY 898
82 WEIGHT DECREASED 894
83 ARTHROPATHY 891
84 INFUSION RELATED REACTION 879
85 DYSPHONIA 878
86 BLISTER 869
87 PRODUCT USE ISSUE 867
88 EYE SWELLING 850
89 TYPE 2 DIABETES MELLITUS 845
90 CONTUSION 839
91 PEMPHIGUS 837
92 FIBROMYALGIA 829
93 PERICARDITIS 827
94 MUSCULOSKELETAL PAIN 826
95 BURSITIS 825
96 SYNOVITIS 822
97 MOBILITY DECREASED 816
98 TASTE DISORDER 812
99 GLOSSODYNIA 811
100 BREAST CANCER STAGE III 802
101 FOLLICULITIS 800
102 JOINT SWELLING 800
103 GAIT DISTURBANCE 796
104 C-REACTIVE PROTEIN INCREASED 795
105 DUODENAL ULCER PERFORATION 793
106 HAND DEFORMITY 778
107 BLOOD CHOLESTEROL INCREASED 775
108 WOUND 774
109 STOMATITIS 772
110 WHEEZING 772
111 VISUAL IMPAIRMENT 771
112 DIPLOPIA 766
113 HELICOBACTER INFECTION 765
114 HEPATIC ENZYME INCREASED 752
115 GAIT INABILITY 750
116 DYSPEPSIA 748
117 FACET JOINT SYNDROME 746
118 INJECTION SITE REACTION 737
119 TREATMENT FAILURE 737
120 OSTEOARTHRITIS 736
121 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 719
122 CONTRAINDICATED PRODUCT ADMINISTERED 718
123 WOUND INFECTION 718
124 IRRITABLE BOWEL SYNDROME 711
125 BOTULISM 710
126 SLEEP DISORDER 710
127 BURNING SENSATION 699
128 LOWER RESPIRATORY TRACT INFECTION 699
129 IMPAIRED HEALING 693
130 TREMOR 690
131 URINARY TRACT INFECTION 688
132 JOINT RANGE OF MOTION DECREASED 685
133 MUSCLE INJURY 680
134 DISCOMFORT 669
135 LUNG DISORDER 665
136 LIP DRY 663
137 DECREASED APPETITE 660
138 BACK PAIN 656
139 HYPERCHOLESTEROLAEMIA 653
140 NIGHT SWEATS 653
141 NAIL DISORDER 640
142 GASTROINTESTINAL DISORDER 639
143 PERIPHERAL VENOUS DISEASE 638
144 DRY EYE 632
145 LIVER INJURY 627
146 LIVE BIRTH 625
147 DRUG EFFECT LESS THAN EXPECTED 624
148 OBESITY 624
149 SPEECH DISORDER 617
150 BROW PTOSIS 614
151 EXPOSURE DURING PREGNANCY 614
152 CHEST PAIN 608
153 MYALGIA 604
154 BACK INJURY 596
155 INJECTION SITE BRUISING 584
156 COUGH 579
157 INJURY 574
158 ONYCHOMADESIS 563
159 PALPITATIONS 558
160 ABDOMINAL PAIN 555
161 ADVERSE DRUG REACTION 553
162 ABDOMINAL DISTENSION 552
163 SEDATION 549
164 RHEUMATIC FEVER 548
165 NIGHTMARE 547
166 INJECTION SITE MASS 546
167 CONSTIPATION 540
168 VERTIGO 530
169 NEPHROLITHIASIS 526
170 SINUSITIS 526
171 POOR QUALITY PRODUCT ADMINISTERED 523
172 SOMNOLENCE 516
173 INJECTION SITE RASH 515
174 GRIP STRENGTH DECREASED 505
175 EYELID OEDEMA 501
176 ILL-DEFINED DISORDER 500
177 ADVERSE EVENT 498
178 EYE PAIN 498
179 ASTHMA 497
180 FACIAL PARALYSIS 492
181 INCORRECT DOSE ADMINISTERED 486
182 LIVER FUNCTION TEST INCREASED 485
183 THERAPY NON-RESPONDER 479
184 DRUG-INDUCED LIVER INJURY 475
185 INJECTION SITE PRURITUS 474
186 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 472
187 SEIZURE 469
188 CEREBROVASCULAR ACCIDENT 466
189 COVID-19 441
190 HEAD DISCOMFORT 430
191 COELIAC DISEASE 426
192 CHEST DISCOMFORT 425
193 ONYCHOMYCOSIS 423
194 URINARY RETENTION 418
195 SWOLLEN TONGUE 416
196 LOSS OF CONSCIOUSNESS 409
197 MUSCLE TWITCHING 408
198 INTENTIONAL PRODUCT MISUSE 404
199 OROPHARYNGEAL PAIN 404
200 C-REACTIVE PROTEIN ABNORMAL 393
201 DYSARTHRIA 392
202 TINNITUS 391
203 UNDERDOSE 389
204 PRESCRIBED OVERDOSE 387
205 FACIAL PAIN 384
206 BALANCE DISORDER 379
207 ADVERSE REACTION 375
208 HEPATITIS 371
209 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 371
210 PRODUCT DOSE OMISSION ISSUE 371
211 SKIN WRINKLING 366
212 ANGIOEDEMA 361
213 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 361
214 INFECTION 356
215 FINGER DEFORMITY 354
216 BLOOD PRESSURE INCREASED 346
217 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 339
218 FACIAL ASYMMETRY 338
219 MUSCLE TIGHTNESS 335
220 CHILLS 333
221 HEART RATE INCREASED 331
222 LACRIMATION INCREASED 330
223 SKIN TIGHTNESS 330
224 PRODUCT LABEL CONFUSION 328
225 ILLNESS 327
226 FEELING HOT 325
227 HYPOTENSION 324
228 SURGERY 323
229 INFLUENZA 319
230 ACCIDENTAL EXPOSURE TO PRODUCT 318
231 PANIC ATTACK 313
232 AMNESIA 312
233 PHOTOPHOBIA 312
234 PERIORBITAL SWELLING 311
235 HOSPITALISATION 306
236 PREGNANCY 304
237 THROAT TIGHTNESS 296
238 EYE DISORDER 294
239 LIP SWELLING 294
240 FOETAL EXPOSURE DURING PREGNANCY 293
241 INJECTION SITE HAEMORRHAGE 289
242 STRESS 289
243 OCULAR HYPERAEMIA 288
244 FLUSHING 284
245 INJECTION SITE URTICARIA 282
246 UNEVALUABLE EVENT 281
247 SYNCOPE 279
248 DRUG EFFECT DECREASED 276
249 MUSCLE SPASTICITY 273
250 PARALYSIS 271
251 URINARY INCONTINENCE 266
252 EAR PAIN 262
253 EYE IRRITATION 262
254 SKIN DISORDER 258
255 CONGENITAL ANOMALY 252
256 ARTHRITIS 247
257 ROAD TRAFFIC ACCIDENT 244
258 INFUSION SITE REACTION 242
259 HYPOAESTHESIA ORAL 239
260 NEURALGIA 238
261 TACHYCARDIA 234
262 DISTURBANCE IN ATTENTION 232
263 SWELLING OF EYELID 232
264 OEDEMA 229
265 DYSGEUSIA 228
266 SKIN DISCOLOURATION 224
267 UPPER RESPIRATORY TRACT INFECTION 218
268 SUICIDAL IDEATION 216
269 PAIN IN JAW 215
270 RESPIRATORY DISORDER 212
271 CHOKING 211
272 PSORIASIS 211
273 AUTOIMMUNE DISORDER 208
274 NEUROMUSCULAR TOXICITY 206
275 OEDEMA PERIPHERAL 206
276 DEHYDRATION 205
277 DYSKINESIA 205
278 ANAPHYLACTIC REACTION 204
279 LETHARGY 200
280 HERPES ZOSTER 198
281 MULTIPLE SCLEROSIS 197
282 APHASIA 196
283 BRONCHITIS 196
284 MASS 195
285 MUSCLE ATROPHY 195
286 INJECTION SITE NODULE 194
287 PRODUCT TEMPERATURE EXCURSION ISSUE 192
288 EYE PRURITUS 191
289 LYMPHADENOPATHY 191
290 THERAPEUTIC RESPONSE UNEXPECTED 191
291 ASTHENOPIA 190
292 IMPAIRED WORK ABILITY 183
293 JOINT STIFFNESS 183
294 LOWER LIMB FRACTURE 183
295 DRUG INTERACTION 179
296 DRUG RESISTANCE 176
297 THROAT IRRITATION 172
298 TOXICITY TO VARIOUS AGENTS 171
299 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 170
300 LARYNGITIS 169
301 INJECTION SITE DISCOMFORT 168
302 RHINORRHOEA 168
303 ACNE 167
304 NERVE INJURY 165
305 RASH ERYTHEMATOUS 165
306 NO ADVERSE EVENT 164
307 PERIORBITAL OEDEMA 164
308 EXOSTOSIS 161
309 MULTIPLE SCLEROSIS RELAPSE 161
310 NASAL CONGESTION 158
311 SENSORY DISTURBANCE 158
312 MOVEMENT DISORDER 156
313 PATIENT DISSATISFACTION WITH TREATMENT 155
314 POOR QUALITY DRUG ADMINISTERED 155
315 RED BLOOD CELL SEDIMENTATION RATE INCREASED 152
316 COGNITIVE DISORDER 151
317 NEUROPATHY PERIPHERAL 151
318 PNEUMONIA ASPIRATION 151
319 MASTICATION DISORDER 150
320 OCULAR DISCOMFORT 150
321 PULMONARY FIBROSIS 150
322 NODULE 149
323 CELLULITIS 148
324 BRAIN FOG 147
325 CYSTITIS 147
326 EAR DISCOMFORT 147
327 MEDICATION ERROR 147
328 DRY SKIN 146
329 INCORRECT ROUTE OF DRUG ADMINISTRATION 146
330 BLINDNESS 145
331 CARDIAC DISORDER 145
332 RESPIRATORY FAILURE 145
333 TENSION HEADACHE 145
334 BREAST CANCER STAGE II 144
335 PRESCRIBED UNDERDOSE 144
336 TENDERNESS 143
337 DYSSTASIA 142
338 OSTEOPOROSIS 142
339 SEPSIS 141
340 CROHN^S DISEASE 140
341 DYSURIA 140
342 CHRONIC KIDNEY DISEASE 139
343 SWOLLEN JOINT COUNT INCREASED 139
344 VISUAL ACUITY REDUCED 139
345 PRESYNCOPE 137
346 DISLOCATION OF VERTEBRA 135
347 RASH PAPULAR 135
348 SCIATICA 135
349 DEPRESSED MOOD 134
350 NORMAL NEWBORN 134
351 ENDOMETRIOSIS 132
352 PRODUCT DISTRIBUTION ISSUE 132
353 BONE EROSION 130
354 DELIRIUM 130
355 LIMB DISCOMFORT 130
356 RASH PRURITIC 130
357 RHEUMATOID FACTOR POSITIVE 130
358 EMOTIONAL DISTRESS 129
359 HALLUCINATION 128
360 DRUG EFFECT INCOMPLETE 127
361 HOT FLUSH 125
362 DISORIENTATION 124
363 ASPIRATION 122
364 BLOOD PRESSURE DECREASED 122
365 EAR INFECTION 122
366 NERVOUSNESS 122
367 VIRAL INFECTION 122
368 HAEMORRHAGE 121
369 INJECTION SITE PAPULE 120
370 MYOCARDIAL INFARCTION 120
371 SKIN EXFOLIATION 119
372 DEVICE DIFFICULT TO USE 118
373 DISABILITY 118
374 INJECTION SITE OEDEMA 118
375 NEOPLASM MALIGNANT 118
376 VIITH NERVE PARALYSIS 118
377 ABORTION SPONTANEOUS 117
378 IRRITABILITY 117
379 PALLOR 117
380 FACE OEDEMA 116
381 NERVOUS SYSTEM DISORDER 116
382 LIVER DISORDER 115
383 OVERLAP SYNDROME 115
384 DEEP VEIN THROMBOSIS POSTOPERATIVE 113
385 INJECTION SITE HAEMATOMA 113
386 MUSCULOSKELETAL DISCOMFORT 113
387 THERAPY CESSATION 113
388 DYSTONIA 112
389 HEPATIC CIRRHOSIS 112
390 HYPOTONIA 112
391 SKIN BURNING SENSATION 112
392 EYE DISCHARGE 111
393 FEEDING DISORDER 111
394 OXYGEN SATURATION DECREASED 111
395 CONCUSSION 110
396 INJECTION SITE INFLAMMATION 110
397 ANAEMIA 109
398 HEAD INJURY 109
399 POOR QUALITY SLEEP 109
400 MUSCULOSKELETAL DISORDER 108
401 POLLAKIURIA 108
402 X-RAY ABNORMAL 107
403 BREAST CANCER 106
404 CRYING 106
405 INCORRECT PRODUCT ADMINISTRATION DURATION 106
406 PARAESTHESIA ORAL 106
407 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 105
408 DROOLING 105
409 EYELID DISORDER 105
410 IMPAIRED DRIVING ABILITY 105
411 APHONIA 104
412 INJECTION SITE DISCOLOURATION 104
413 MENTAL DISORDER 104
414 MUSCLE DISORDER 103
415 PRODUCT DOSE OMISSION 102
416 TORTICOLLIS 102
417 LUPUS VULGARIS 101
418 SINUS DISORDER 101
419 WHITE BLOOD CELL COUNT DECREASED 101
420 CATARACT 100
421 CONVULSION 100
422 JOINT DISLOCATION 100
423 THERAPY INTERRUPTED 100
424 WHITE BLOOD CELL COUNT INCREASED 100
425 ATRIAL FIBRILLATION 98
426 DRUG DOSE OMISSION BY DEVICE 98
427 PULMONARY EMBOLISM 98
428 BONE PAIN 97
429 DRUG ADMINISTERED AT INAPPROPRIATE SITE 97
430 FREQUENT BOWEL MOVEMENTS 97
431 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 97
432 HYPOACUSIS 96
433 INCORRECT PRODUCT STORAGE 96
434 LUPUS-LIKE SYNDROME 96
435 PRODUCT ADMINISTRATION ERROR 96
436 LAGOPHTHALMOS 95
437 SCAR 95
438 ULCER HAEMORRHAGE 95
439 EYE MOVEMENT DISORDER 94
440 FACIAL DISCOMFORT 93
441 DEPRESSED LEVEL OF CONSCIOUSNESS 92
442 EXPIRED PRODUCT ADMINISTERED 92
443 PRODUCT DISPENSING ERROR 92
444 PHARYNGEAL OEDEMA 91
445 BODY TEMPERATURE INCREASED 90
446 TRISMUS 90
447 VITREOUS FLOATERS 90
448 DRUG SPECIFIC ANTIBODY 89
449 FACIAL SPASM 89
450 INJECTION SITE WARMTH 89
451 PRODUCTIVE COUGH 89
452 MADAROSIS 88
453 TRANSIENT ISCHAEMIC ATTACK 87
454 DEVICE ISSUE 86
455 HEMIPARESIS 86
456 DRUG TOLERANCE 85
457 RECTAL HAEMORRHAGE 85
458 MYDRIASIS 84
459 RESPIRATORY TRACT INFECTION 84
460 THROMBOSIS 84
461 INJECTION SITE INDURATION 83
462 MENTAL IMPAIRMENT 83
463 PHOTOSENSITIVITY REACTION 83
464 SENSATION OF FOREIGN BODY 83
465 IMPAIRED GASTRIC EMPTYING 82
466 TOOTHACHE 82
467 DEAFNESS 81
468 DRUG DOSE OMISSION 81
469 INJECTION SITE HYPOAESTHESIA 81
470 LIP DISORDER 81
471 MYASTHENIA GRAVIS 81
472 POST PROCEDURAL COMPLICATION 81
473 POSTURE ABNORMAL 81
474 RASH GENERALISED 81
475 SNEEZING 81
476 KNEE ARTHROPLASTY 80
477 MIDDLE INSOMNIA 80
478 PANCREATITIS 80
479 PRODUCT COMPLAINT 80
480 AGITATION 79
481 FEAR 79
482 FEELING COLD 79
483 PAIN OF SKIN 79
484 SLEEP APNOEA SYNDROME 79
485 SPINAL OPERATION 79
486 STRABISMUS 79
487 EATING DISORDER 78
488 EYE CONTUSION 78
489 RIB FRACTURE 78
490 ACTIVITIES OF DAILY LIVING IMPAIRED 77
491 EXTRAPYRAMIDAL DISORDER 77
492 FLUID RETENTION 77
493 HEART RATE DECREASED 77
494 INJECTION SITE PARAESTHESIA 77
495 ABNORMAL SENSATION IN EYE 76
496 EYELID SENSORY DISORDER 76
497 BRAIN INJURY 75
498 HEPATIC ENZYME 75
499 INJECTION SITE HYPERSENSITIVITY 75
500 INTERVERTEBRAL DISC PROTRUSION 75
501 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 75
502 PRODUCT PHYSICAL ISSUE 75
503 MICTURITION URGENCY 74
504 PARADOXICAL DRUG REACTION 74
505 AGEUSIA 73
506 BELL^S PALSY 73
507 BLADDER DISORDER 73
508 PRURITUS GENERALISED 73
509 RASH MACULAR 73
510 BEDRIDDEN 71
511 ECZEMA 71
512 GENERAL PHYSICAL CONDITION ABNORMAL 71
513 ARRHYTHMIA 70
514 HYPOCHOLESTEROLAEMIA 70
515 HYPOTHYROIDISM 70
516 COLITIS ULCERATIVE 69
517 INCONTINENCE 69
518 INJECTION SITE IRRITATION 69
519 VISUAL FIELD DEFECT 69
520 WALKING AID USER 69
521 HEART RATE IRREGULAR 68
522 HYPERACUSIS 68
523 HYPOKINESIA 68
524 MEPHISTO SIGN 68
525 ANGINA PECTORIS 67
526 BLOOD GLUCOSE INCREASED 67
527 CARDIAC ARREST 66
528 CHOKING SENSATION 66
529 ERYTHEMA OF EYELID 66
530 SUSPECTED COUNTERFEIT PRODUCT 66
531 COLD SWEAT 65
532 DIABETES MELLITUS 65
533 EYE INFECTION 65
534 PRODUCT PACKAGING ISSUE 65
535 RETINITIS 65
536 SINUS CONGESTION 65
537 SKIN IRRITATION 65
538 THERAPY PARTIAL RESPONDER 65
539 EPISTAXIS 64
540 HIP ARTHROPLASTY 64
541 INSURANCE ISSUE 64
542 PARANASAL SINUS DISCOMFORT 64
543 RESPIRATORY DISTRESS 64
544 SALIVARY HYPERSECRETION 64
545 SKIN MASS 64
546 SUSPECTED PRODUCT QUALITY ISSUE 64
547 TRIGEMINAL NEURALGIA 64
548 ANURIA 63
549 BRADYCARDIA 63
550 MUSCLE CONTRACTIONS INVOLUNTARY 63
551 ABASIA 62
552 BACK DISORDER 62
553 FACIAL PALSY 62
554 IMPAIRED QUALITY OF LIFE 62
555 LOCAL SWELLING 62
556 OPHTHALMOPLEGIA 62
557 PANIC REACTION 62
558 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 62
559 DEFORMITY 61
560 EMOTIONAL DISORDER 61
561 HAEMATOMA 61
562 INJECTION SITE INDENTATION 61
563 LIMB INJURY 61
564 C-REACTIVE PROTEIN 60
565 DEEP VEIN THROMBOSIS 60
566 DRUG SPECIFIC ANTIBODY PRESENT 60
567 FOOT DEFORMITY 60
568 HAEMOGLOBIN DECREASED 60
569 HYPERAESTHESIA 60
570 MYOSITIS 60
571 NEOVASCULARISATION 60
572 ANAPHYLACTIC SHOCK 59
573 HYPOPHAGIA 59
574 INJECTION SITE VESICLES 59
575 KIDNEY INFECTION 59
576 ORAL DISCOMFORT 59
577 SKIN INDENTATION 59
578 SKIN LESION 59
579 FUNGAL INFECTION 58
580 LABORATORY TEST ABNORMAL 58
581 PHARYNGEAL SWELLING 58
582 POST-TRAUMATIC NECK SYNDROME 58
583 THINKING ABNORMAL 58
584 CONJUNCTIVITIS 57
585 DRY THROAT 57
586 IMMUNODEFICIENCY 57
587 MATERNAL EXPOSURE TIMING UNSPECIFIED 57
588 OROPHARYNGEAL DISCOMFORT 57
589 PRODUCT CONTAINER ISSUE 57
590 RESTLESS LEGS SYNDROME 57
591 APPLICATION SITE PAIN 56
592 HAEMATURIA 56
593 HYPERSOMNIA 56
594 OTITIS MEDIA 56
595 SEASONAL ALLERGY 56
596 STAPHYLOCOCCAL INFECTION 56
597 THIRST 56
598 OCCUPATIONAL EXPOSURE TO PRODUCT 55
599 PROCEDURAL PAIN 55
600 THERAPEUTIC RESPONSE DELAYED 55
601 BLINDNESS UNILATERAL 54
602 BLOOD POTASSIUM DECREASED 54
603 DERMATITIS 54
604 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 54
605 INCORRECT PRODUCT FORMULATION ADMINISTERED 54
606 MOTOR DYSFUNCTION 54
607 MUSCLE RIGIDITY 54
608 ANOSMIA 53
609 DERMATITIS CONTACT 53
610 DEVICE MALFUNCTION 53
611 DYSPNOEA EXERTIONAL 53
612 MOOD ALTERED 53
613 MUSCLE STRAIN 53
614 ORAL PAIN 53
615 PORPHYRIA ACUTE 53
616 SEROTONIN SYNDROME 53
617 THERAPEUTIC PRODUCT EFFECT VARIABLE 53
618 PRE-EXISTING CONDITION IMPROVED 52
619 RASH VESICULAR 52
620 SPINAL PAIN 52
621 THERAPEUTIC PRODUCT EFFECT DELAYED 52
622 BLINDNESS TRANSIENT 51
623 CEREBRAL HAEMORRHAGE 51
624 ELECTRIC SHOCK SENSATION 51
625 GUILLAIN-BARRE SYNDROME 51
626 HIP FRACTURE 51
627 HYPOAESTHESIA FACIAL 51
628 INTESTINAL OBSTRUCTION 51
629 MONOPLEGIA 51
630 ORAL HERPES 51
631 PHOTOPSIA 51
632 TREATMENT NONCOMPLIANCE 51
633 COMA 50
634 CYST 50
635 FOREIGN BODY SENSATION IN EYES 50
636 PERIPHERAL COLDNESS 50
637 PRODUCT ADMINISTRATION INTERRUPTED 50
638 PRODUCT PACKAGING QUANTITY ISSUE 50
639 RENAL FAILURE 50
640 ACUTE KIDNEY INJURY 49
641 HYPOKALAEMIA 49
642 JAW DISORDER 49
643 PAPULE 49
644 PRODUCT SUPPLY ISSUE 49
645 RESPIRATORY ARREST 49
646 RETCHING 49
647 SKIN HYPERPIGMENTATION 49
648 DIVERTICULITIS 48
649 GASTROENTERITIS VIRAL 48
650 HYPERTONIC BLADDER 48
651 MIGRAINE WITH AURA 48
652 SENSORY LOSS 48
653 SEPTIC SHOCK 48
654 TOOTH DISORDER 48
655 WITHDRAWAL SYNDROME 48
656 CHOLELITHIASIS 47
657 GASTRIC DISORDER 47
658 MASTOIDITIS 47
659 PARKINSON^S DISEASE 47
660 PAROSMIA 47
661 REDUCED FACIAL EXPRESSION 47
662 SECRETION DISCHARGE 47
663 VOCAL CORD PARALYSIS 47
664 DEAFNESS UNILATERAL 46
665 DRUG ABUSE 46
666 GENERALISED TONIC-CLONIC SEIZURE 46
667 INJECTION SITE INFECTION 46
668 PERSONALITY DISORDER 46
669 RENAL DISORDER 46
670 THYROID DISORDER 46
671 TONGUE DISORDER 46
672 BACTERIAL INFECTION 45
673 BLADDER SPASM 45
674 BLOOD PRESSURE FLUCTUATION 45
675 DRUG DEPENDENCE 45
676 EYE INJURY 45
677 EYELID FUNCTION DISORDER 45
678 FLATULENCE 45
679 FOOT FRACTURE 45
680 HAEMORRHOIDS 45
681 LIBIDO INCREASED 45
682 PRODUCT USED FOR UNKNOWN INDICATION 45
683 SCAB 45
684 SINUS HEADACHE 45
685 SOFT TISSUE INJURY 45
686 WEIGHT FLUCTUATION 45
687 ANAL INCONTINENCE 44
688 BLOOD CREATINE PHOSPHOKINASE INCREASED 44
689 BRUXISM 44
690 CARDIAC FAILURE 44
691 ELECTROCARDIOGRAM QT PROLONGED 44
692 GASTRITIS 44
693 HOSTILITY 44
694 PARANASAL CYST 44
695 RESPIRATORY TRACT CONGESTION 44
696 SENSATION OF HEAVINESS 44
697 STERNAL FRACTURE 44
698 ABNORMAL BEHAVIOUR 43
699 ANGER 43
700 EYELID PAIN 43
701 INTENTIONAL DOSE OMISSION 43
702 MUSCLE FATIGUE 43
703 NASAL DISCOMFORT 43
704 PELVIC PAIN 43
705 RESTLESSNESS 43
706 VASCULAR MALFORMATION 43
707 CARPAL TUNNEL SYNDROME 42
708 IMMUNE SYSTEM DISORDER 42
709 LID SULCUS DEEPENED 42
710 PNEUMOTHORAX 42
711 RAYNAUD^S PHENOMENON 42
712 TEMPOROMANDIBULAR JOINT SYNDROME 42
713 ALANINE AMINOTRANSFERASE INCREASED 41
714 BLADDER PAIN 41
715 CARDIO-RESPIRATORY ARREST 41
716 CEREBRAL INFARCTION 41
717 PERONEAL NERVE PALSY 41
718 PREMATURE BABY 41
719 BREAST CANCER FEMALE 40
720 DEMENTIA 40
721 FOOD ALLERGY 40
722 GLAUCOMA 40
723 JOINT INJURY 40
724 NEUROLOGICAL SYMPTOM 40
725 SPINAL FUSION SURGERY 40
726 UNRESPONSIVE TO STIMULI 40
727 ATAXIA 39
728 DENTAL CARIES 39
729 DISEASE PROGRESSION 39
730 HYPOGLYCAEMIA 39
731 HYPONATRAEMIA 39
732 INCORRECT DOSE ADMINISTERED BY DEVICE 39
733 INTERVERTEBRAL DISC DEGENERATION 39
734 LEUKOPENIA 39
735 LYMPHOCYTE COUNT DECREASED 39
736 MOUTH SWELLING 39
737 TEMPERATURE INTOLERANCE 39
738 BRAIN NEOPLASM 38
739 HYPERTONIA 38
740 HYSTERECTOMY 38
741 INFUSION SITE PAIN 38
742 INITIAL INSOMNIA 38
743 OCCIPITAL NEURALGIA 38
744 PHARYNGEAL HYPOAESTHESIA 38
745 SPINAL OSTEOARTHRITIS 38
746 ACCIDENTAL OVERDOSE 37
747 DERMATITIS ATOPIC 37
748 DRUG WITHDRAWAL SYNDROME 37
749 HEMIPLEGIA 37
750 POISONING 37
751 PRODUCT ADMINISTERED FROM UNAUTHORISED PROVIDER 37
752 SKIN LACERATION 37
753 SKIN REACTION 37
754 UPPER-AIRWAY COUGH SYNDROME 37
755 BIPOLAR DISORDER 36
756 BLEPHARITIS 36
757 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 36
758 DYSGRAPHIA 36
759 FEELING DRUNK 36
760 FORMICATION 36
761 GENERAL SYMPTOM 36
762 HERNIA 36
763 HORDEOLUM 36
764 MATERNAL EXPOSURE DURING BREAST FEEDING 36
765 NERVE COMPRESSION 36
766 DARK CIRCLES UNDER EYES 35
767 DERMATITIS ALLERGIC 35
768 MOUTH ULCERATION 35
769 NYSTAGMUS 35
770 SKIN SWELLING 35
771 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 35
772 APPLICATION SITE ERYTHEMA 34
773 BLOOD GLUCOSE DECREASED 34
774 CYANOSIS 34
775 EYE INFLAMMATION 34
776 EYELIDS PRURITUS 34
777 FEMUR FRACTURE 34
778 FOOD INTOLERANCE 34
779 INJECTION SITE SCAR 34
780 LOCALISED INFECTION 34
781 MATERNAL EXPOSURE BEFORE PREGNANCY 34
782 MOOD SWINGS 34
783 MUSCULOSKELETAL CHEST PAIN 34
784 NEPHROPATHY TOXIC 34
785 ORAL DISORDER 34
786 POST-TRAUMATIC STRESS DISORDER 34
787 SKIN INFECTION 34
788 TOOTH FRACTURE 34
789 WRONG PRODUCT ADMINISTERED 34
790 ABNORMAL DREAMS 33
791 ARTHROPOD BITE 33
792 CANDIDA INFECTION 33
793 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 33
794 DRUG ERUPTION 33
795 INJECTION SITE GRANULOMA 33
796 INJURY ASSOCIATED WITH DEVICE 33
797 NEEDLE ISSUE 33
798 PLATELET COUNT DECREASED 33
799 PLEURAL EFFUSION 33
800 PUSTULAR PSORIASIS 33
801 RHABDOMYOLYSIS 33
802 ALTERED STATE OF CONSCIOUSNESS 32
803 BLOOD URINE PRESENT 32
804 CENTRAL NERVOUS SYSTEM LESION 32
805 CEREBRAL DISORDER 32
806 DRUG ADMINISTRATION ERROR 32
807 FEELING JITTERY 32
808 HYPOAESTHESIA EYE 32
809 MULTIPLE ALLERGIES 32
810 PHARYNGITIS STREPTOCOCCAL 32
811 QUALITY OF LIFE DECREASED 32
812 CHOLECYSTECTOMY 31
813 COORDINATION ABNORMAL 31
814 DIZZINESS POSTURAL 31
815 EYE HAEMORRHAGE 31
816 GINGIVAL PAIN 31
817 HERPES VIRUS INFECTION 31
818 HYPOXIA 31
819 MENSTRUAL DISORDER 31
820 PARTIAL SEIZURES 31
821 RENAL PAIN 31
822 SKIN WARM 31
823 TARDIVE DYSKINESIA 31
824 UPPER LIMB FRACTURE 31
825 VITAMIN D DECREASED 31
826 AUTONOMIC NERVOUS SYSTEM IMBALANCE 30
827 BLOOD CREATININE INCREASED 30
828 BLOOD PRESSURE ABNORMAL 30
829 COUNTERFEIT PRODUCT ADMINISTERED 30
830 DEVICE DISLOCATION 30
831 ECONOMIC PROBLEM 30
832 EXTRAOCULAR MUSCLE PARESIS 30
833 EYE OEDEMA 30
834 HAEMATOCHEZIA 30
835 KNEE OPERATION 30
836 LIP PAIN 30
837 MUSCLE HYPERTROPHY 30
838 MYOCLONUS 30
839 PHARYNGITIS 30
840 POSTNATAL GROWTH RESTRICTION 30
841 RASH PUSTULAR 30
842 RETINAL DETACHMENT 30
843 SPONDYLITIS 30
844 TENDONITIS 30
845 UROSEPSIS 30
846 ADRENAL INSUFFICIENCY 29
847 DEVICE BREAKAGE 29
848 FINE MOTOR SKILL DYSFUNCTION 29
849 HEPATIC FUNCTION ABNORMAL 29
850 INJECTION SITE INJURY 29
851 LACERATION 29
852 LIGAMENT SPRAIN 29
853 NEUROGENIC BLADDER 29
854 ON AND OFF PHENOMENON 29
855 POST PROCEDURAL INFECTION 29
856 ROTATOR CUFF SYNDROME 29
857 SINUS PAIN 29
858 SPINAL FRACTURE 29
859 TOOTH INFECTION 29
860 VAGINAL HAEMORRHAGE 29
861 VITAMIN D DEFICIENCY 29
862 ACUTE RESPIRATORY FAILURE 28
863 ASPHYXIA 28
864 CARDIAC FAILURE CONGESTIVE 28
865 DECUBITUS ULCER 28
866 DERMATOCHALASIS 28
867 DRUG TOLERANCE DECREASED 28
868 EYELID IRRITATION 28
869 FACE INJURY 28
870 GASTRIC ULCER 28
871 GESTATIONAL HYPERTENSION 28
872 HIATUS HERNIA 28
873 INJECTION SITE EXTRAVASATION 28
874 INTRACRANIAL PRESSURE INCREASED 28
875 ODYNOPHAGIA 28
876 PRODUCT PRESCRIBING ISSUE 28
877 PRODUCT SUBSTITUTION ISSUE 28
878 SKIN CANCER 28
879 SUSPECTED OFF LABEL USE 28
880 SWOLLEN JOINT COUNT 28
881 TENSION 28
882 ABDOMINAL PAIN LOWER 27
883 ACCIDENT 27
884 APNOEA 27
885 DYSPHEMIA 27
886 FEELING OF BODY TEMPERATURE CHANGE 27
887 GASTROINTESTINAL MOTILITY DISORDER 27
888 NECK SURGERY 27
889 OBSTRUCTIVE AIRWAYS DISORDER 27
890 PARESIS 27
891 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 27
892 PRODUCT ADMINISTERED BY WRONG PERSON 27
893 PRODUCT AVAILABILITY ISSUE 27
894 RENAL IMPAIRMENT 27
895 SKIN LAXITY 27
896 SPINAL STENOSIS 27
897 ULCER 27
898 AGGRESSION 26
899 ARTERIOSCLEROSIS CORONARY ARTERY 26
900 ATROPHY 26
901 AURA 26
902 AUTOIMMUNE THYROIDITIS 26
903 COLITIS 26
904 CYSTITIS NONINFECTIVE 26
905 FRACTURE 26
906 FRUSTRATION TOLERANCE DECREASED 26
907 GRANULOMA 26
908 HEAD TITUBATION 26
909 HYDROCEPHALUS 26
910 HYPERVENTILATION 26
911 INJECTION SITE ATROPHY 26
912 PROCEDURAL COMPLICATION 26
913 PRODUCT CONTAMINATION 26
914 PRODUCT LABEL ISSUE 26
915 SKIN ATROPHY 26
916 SKIN ODOUR ABNORMAL 26
917 STATUS EPILEPTICUS 26
918 STRIDOR 26
919 TONGUE PARALYSIS 26
920 TOOTH LOSS 26
921 URINARY BLADDER HAEMORRHAGE 26
922 APPLICATION SITE PRURITUS 25
923 CLOSTRIDIUM DIFFICILE INFECTION 25
924 EXPOSURE VIA BREAST MILK 25
925 EXPOSURE VIA SKIN CONTACT 25
926 EYE OPERATION 25
927 INCREASED TENDENCY TO BRUISE 25
928 INJECTION RELATED REACTION 25
929 MACULAR DEGENERATION 25
930 MANUFACTURING PRODUCT SHIPPING ISSUE 25
931 MENTAL STATUS CHANGES 25
932 NASAL DRYNESS 25
933 PRODUCT USE COMPLAINT 25
934 PSYCHOTIC DISORDER 25
935 PULMONARY OEDEMA 25
936 RHINALGIA 25
937 SCOLIOSIS 25
938 SKIN ULCER 25
939 SUDDEN DEATH 25
940 SUPRAVENTRICULAR TACHYCARDIA 25
941 ANKLE FRACTURE 24
942 ASPARTATE AMINOTRANSFERASE INCREASED 24
943 CERVICOGENIC HEADACHE 24
944 GASTROENTERITIS 24
945 GASTROINTESTINAL PAIN 24
946 HAIR TEXTURE ABNORMAL 24
947 IMMUNOSUPPRESSION 24
948 INCREASED UPPER AIRWAY SECRETION 24
949 INDURATION 24
950 IRON DEFICIENCY ANAEMIA 24
951 LEFT VENTRICULAR FAILURE 24
952 LIQUID PRODUCT PHYSICAL ISSUE 24
953 MALNUTRITION 24
954 MAST CELL ACTIVATION SYNDROME 24
955 MULTIPLE ORGAN DYSFUNCTION SYNDROME 24
956 NASAL OEDEMA 24
957 NEOPLASM 24
958 NO THERAPEUTIC RESPONSE 24
959 NONSPECIFIC REACTION 24
960 OESOPHAGEAL DISORDER 24
961 ORTHOSTATIC HYPOTENSION 24
962 PHARYNGEAL DISORDER 24
963 PRODUCT DOSE OMISSION IN ERROR 24
964 PRODUCT PRESCRIBING ERROR 24
965 RED BLOOD CELL COUNT DECREASED 24
966 RESIDUAL URINE VOLUME INCREASED 24
967 SUICIDE ATTEMPT 24
968 THROMBOCYTOPENIA 24
969 VENTRICULAR EXTRASYSTOLES 24
970 VOCAL CORD DISORDER 24
971 APPENDICITIS 23
972 AREFLEXIA 23
973 CARDIOVASCULAR DISORDER 23
974 CHEILITIS 23
975 DRUG TOXICITY 23
976 EXTRA DOSE ADMINISTERED 23
977 FAECAL INCONTINENCE 23
978 HORMONE LEVEL ABNORMAL 23
979 LIMB OPERATION 23
980 MENOPAUSE 23
981 MIGRAINE WITHOUT AURA 23
982 NOCTURIA 23
983 PHYSICAL DECONDITIONING 23
984 ROSACEA 23
985 SENSATION OF PRESSURE 23
986 SENSITIVE SKIN 23
987 SHOULDER OPERATION 23
988 SKIN HAEMORRHAGE 23
989 SLOW SPEECH 23
990 SYMPTOM RECURRENCE 23
991 VASCULAR OCCLUSION 23
992 VEIN DISORDER 23
993 CIRCULATORY COLLAPSE 22
994 CUTIS LAXA 22
995 EXCESSIVE EYE BLINKING 22
996 EXOPHTHALMOS 22
997 FACE LIFT 22
998 FOOD POISONING 22
999 HAEMORRHAGE SUBCUTANEOUS 22